Advertisement
Advertise Here
-
September 12, 2011 - Volume 89, Number 37
- p. 12
Business Concentrates
More Business Concentrates
- Adidas, Nike, And Puma Commit To Zero Discharge
- In response to a challenge posed by the environmental group Greenpeace, sportswear makers Adidas, Nike, and Puma have committed to eliminating...
- PerkinElmer Will Buy Caliper Life Sciences
- Scientific and diagnostic instrument maker PerkinElmer has agreed to acquire Caliper Life Sciences, a molecular and tissue imaging expert...
- Frontier Scientific Purchases ASDI
- Frontier Scientific has acquired the assets of ASDI in a bankruptcy auction. Based in Newark, Del...
- BASF Signs Deal For Rare Earths
- BASF has agreed to source, on a long-term basis, the rare-earth element lanthanum from a plant being built in Kuantan, Malaysia...
- Dupont Sues Heraeus Over Solar Pastes
- DuPont has sued the German specialty materials maker Heraeus for infringing a DuPont patent on metallization pastes...
- BASF, Daimler Design Urban Electric Car
- BASF and Daimler have joined forces to design a concept electric vehicle, the Smart Forvision, for urban markets...
- Evotec, Roche Join For Alzheimer’s Drug
- Evotec and Roche are partnering to develop Evotec’s EVT 302, an inhibitor of monoamine oxidase type B (MAO-B)...
- Lanxess Expands Glass In Antwerp
- Lanxess will spend $21 million to increase glass fiber capacity in Antwerp, Belgium, by 10% to 60,000 metric tons per year...
- Eastman Acquires Plasticizer Maker
- Eastman Chemical has acquired Scandiflex, a manufacturer of plasticizers based in Mauá, São Paulo, Brazil...
- Saint-Gobain Plans New Proppants Plant
- Saint-Gobain will spend $100 million to build a proppants plant in Saline County, Ark. To be constructed on a 70-acre parcel of land...
- Pfizer Inks Deal For Space At MIT
- Pfizer has signed a 10-year lease on 180,000 sq ft of space in a building being constructed in Cambridge, Mass....
- Two Biotech Firms Get Back Drug Rights
- Citing portfolio reassessment, two drug companies are returning pharmaceutical development rights to biotech partners. Merck & Co. has returned...
- Anacor Extends R&D Deals
- Anacor Pharmaceuticals has expanded R&D collaborations for its boron-based anti-infective agents....
- Business Roundup
- Solutia, Evonik Industries, Linde, BASF Canada, International Flavors & Fragrances, Amakem, Merck Serono ...
Topics Covered
More Business Stories
October 24, 2011
Celanese Takes An Ethanol Plunge (Member Content)
(October 24, 2011 | Vol. 89 Issue 43 | pp. 20-21)The chemical producer seeks to make ethanol a major business but is secretive about details of its process.
Building On The Momentum (Member Content)
(October 24, 2011 | Vol. 89 Issue 43 | p. 22)BWA Water Additives rides crest of rising demand for specialty water treatment chemicals.
European Firms Invest In China
(October 24, 2011 | Vol. 89 Issue 43 | p. 6)Specialty Chemicals: Companies pursue local research and production.
Investors Bet On Cleantech
(October 24, 2011 | Vol. 89 Issue 43 | p. 9)Green Chemistry: Close to $1 billion is slated for start-up firms.
Business Concentrates (Member Content)
(October 24, 2011 | Vol. 89 Issue 43 | p. 18)
October 17, 2011
Emerging Strategies
(October 17, 2011 | Vol. 89 Issue 42 | pp. 15-26)Faced with change, pharmaceutical firms shift business mix to generics and emerging markets.
A Sense of Urgency (Member Content)
(October 17, 2011 | Vol. 89 Issue 42 | pp. 30-32)Call for drug safety pushes the mundane art of supply chain management to the front burner.
Growing Businesses The Scottish Way (Member Content)
(October 17, 2011 | Vol. 89 Issue 42 | pp. 33-35)Development authorities seek to harness industry‑academia cooperation in the life sciences.
An Update On Dow (Member Content)
(October 17, 2011 | Vol. 89 Issue 42 | pp. 36-38)CEO Andrew N. Liveris believes the major pieces are in place to continue the company's transformation.
AstraZeneca Shifts Operations
(October 17, 2011 | Vol. 89 Issue 42 | p. 10)Pharmaceuticals: Firm will add manufacturing in China while cutting jobs in the U.S.
Investment Deterrent
(October 17, 2011 | Vol. 89 Issue 42 | p. 11)Venture capital firms say FDA regulations hamper their support of biopharma companies.
Business Concentrates (Member Content)
(October 17, 2011 | Vol. 89 Issue 42 | pp. 28-30)
DuPont has sued the German specialty materials maker Heraeus for infringing a DuPont patent on metallization pastes used to make crystalline silicon and thin-film solar cells. The suit, filed in U.S. District Court for the District of Delaware, seeks unspecified damages and an injunction preventing Heraeus from infringing the patent. Heraeus says it will vigorously defend itself against the infringement claim. “We respect the intellectual property rights of others and carefully monitor industry developments to ensure full compliance,” says Andy London, manager of Heraeus’ photovoltaic unit.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © 2011 American Chemical Society
Services & Tools
ACS Resources
ACS Careers
ACS is the leading employment source for recruiting scientific professionals. ACS Careers and C&EN Classifieds provide employers direct access to scientific talent both in print and online. Jobseekers | Employers
» Join ACS
Join more than 161,000 professionals in the chemical sciences world-wide, as a member of the American Chemical Society.
» Join Now!
Popular Sections
ACS, Analytical SCENE, Business, Careers, Economy, Editor, Education, Employment, Environmental SCENE, Letters, Government, Photo Galleries, Policy, Movies, Multimedia, Nanotechnology, Newscripts, Reel Science, Safety Letters, Science, Stem Cells, Stimulus Funds, Technology, Vaccines, Videos, What's That Stuff
Advertisements
